Immunosuppresson - Rheumatology Flashcards

1
Q

What is rheumatoid arthritis?

A

An autoimmune multi-system disease

Family common: UK prevalence of 1%

Initially localised to synovium

Inflammatory change and proliferation of synovial (pannus) and leading to dissolution of cartilage and bone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the pathogenesis of RA

A

Immune system becomes hyperactive.

The over expression of metalloproteinases leads to inflammation of the joints and thickening of the joint capsule.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How do we diagnose RA??

A
Clinical criteria:
Morning stiffness >1hour
Arthritis of >3 joints
Arthritis of hand joins 
Symmetrical arthritis 
Rheumatoid nodules 

Non clinical:
Serum rheumatoid factor / Anti-CCP antibodies
X-Ray changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the goals of RA treatment?

A

Symptom relief

Prevention of joint destruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe the treatment strategy of RA

A
Early use of disease-modifying drugs 
Aim to achieve good disease control 
Use of adequate dosages 
Use of combinations of drugs 
Avoidance of long-term corticosteroids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is SLE?

A

It is an autoimmune disease in which the immune system attaches many different systems of the body.

Called lupus as the lupus rash looks like you have been bitten by a wolf.

Symptoms vary between people and may be mild to severe.Common symptoms include painful and swollen joints, fever, chest pain, hair loss, mouth ulcers, swollen lymph nodes, feeling tired, and a red rash which is most commonly on the face

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is vasculitis?

A

Vasculitis is a group of disorders that destroy blood vessels by inflammation.[2] Both arteries and veins are affected.

L - leukocytic infultrates
F - fibrosis
T - thrombosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the treatment goals in SLE and vasculitis?

A

Symptomatic relief

Reduction in mortality

Prevention of organ damage

Reduction in long term morbidity caused by disease and by drugs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Give examples of some Immunosuppressants

A
Corticosteroids 
Methotrexate 
Azathioprine 
Cyclosporin
Tacrolimus 
Mycophenolate mofetil
Leflunomide
Cyclophosphamide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How do corticosteroids work?

A

Prevent IL-1 and IL-6 production by macrophages.

Inhibits all stages of T cell activation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the side effects fo steroids?

A
Osteoporosis
Buffalo hump
Heart attack
High cholesterol
Cararacrs
Trunk obesity
Diabetes
Glaucoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are examples of some other DMARDs?

A

Non biologics:
Sulphasalazine
Hydroxychloriquinine

Biologics:
Anti-TNF
Rituximab
IL-6 inhibitors, JAK inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is Azathioprine used for?

A

SLE and vasculitis as maintenance therapy
RA - very weak evidence
IBD
Dermatitis - Bullous skin disease

Many other uses as a ‘steroid sparing’ drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the pharmacodynamics of azathioprine

A

Either Azathioprine or 6-MP as 6-MP is metabolised by TPMP

6-MP better tolerated if vomiting - but, used more by GI

Need to check TPMT levels as it is highly polymorphic so a low /absent TPMT results in a risk of myelosupression.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the MOA of azathioprine

A

Azathioprine is a prodrug.

At first it is slowly and almost completely converted to 6-mercaptopurine (6-MP) by reductive cleavage of the thioether (–S–).

6-MP is metabolized analogously to natural purines, giving thioguanosine triphosphate (TGTP) and thio-deoxyguanosine triphosphate (TdGTP) via thioinosine monophosphate (TIMP) and several further intermediates.

On a second path, the sulfur atom of 6-MP and TIMP is methylated. The end products of azathioprine metabolism are thiouric acid (38%) and various methylated and hydroxylated purines, which are excreted via the urine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the ADRs of Azathioprine?

A

Bone marrow suppression — monitor FBC

Increased risk of malignancy

Increase risk of infection

Hepatitis - monitor LFT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are cacineurin inhibitors side for?

A

Cyclosporine and tacrolimus widely used in transplantation.

Also for topic dermatitis and psoriasis

Not often used in rheumatology because of renal toxicity (need to check BP and eGFR regularly)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Give examples of CYP P450 inducers

A

Rifampicin
Carbemazepine
Phenytoin
Omeprazole

19
Q

Give examples of CYP P450 inhibitors

A
Ciprofloxacin
Many antifungals
Fluoxetine (SSRI)
Paroxetine
HIV antivirals
20
Q

Describe MOA of cyclosporine and tacrolimus

A

Active against helper T cells, preventing production of IL-2 via calcineurin inhibition.

Ciclosporin binds to cyclophilin protein.

Tracrolimus binds to tacrolimus-binding protein

Drug/protein complexes bind calcineurin.

Calcineurin exerts phosphatase activity of activated T-cells then nuclear factor migration starts IL-2 transcription.

21
Q

What is mycophenolate?

A

Primarily in transplantation.

Good efficacy as induction and maintenance therapy for lupus nephritis / Vasculitis maintenance.

22
Q

What is the MOA of mycophenolate mofetil?

A

Is a rod rug derived from fungus Penicillium stoloniferum.

Inhibits inosine monosulphate dehydrogenase (required to make guanine)

Impairs B and T cell proliferation

Spares other rapidly dividing cells (due to guanosine salvage pathways in other cells)

23
Q

What are the ADRs of mycophenolate mofetil?

A

Nausea, vomiting, diarrhoea

Most serious = myelosuppression

24
Q

What is cyclophosphamide?

A

Cytotoxic agent:
Alkylating agent - cross links DNA so that it cannot replicate.

Many immunological effects:
Suppresses T and B cell activity.

25
Q

What are the indications of cyclophosphamide?

A

Lymphoma, Leukaemia, solid cancers, Lupus nephritis, Wegener’s granulomatosis (ANCA-vasculitis)

26
Q

Describe the pharmacodynamics of cyclophosphamide

A

Prodrug

Converted in the liver (CYP450)to active forms

Main active metabolite = 4-hydroxyclyclophosphamide

This exists in equilibrium with its tautomer, aldophosphamide

Most of aldophosphamide is oxidised to make carboxyphosphamide. A small proportion of aldophosphamide is converted into phosphoramide mustard.

27
Q

Describe pharmacokinetics of cyclophosphamide

A

Excreted by the kidney

Acrolein, another metabolite, is toxic to the bladder epithelium and can led to haemorrhagic cystitis.

This can be prevented through the use of aggressive hydration and / or Mesna

28
Q

What are the important considerations of cyclophosphamide?

A

Significant toxicity.

  • Increased risk of bladder cancer, lymphoma and leukaemia.
  • Infertility: Risk relates to cumulative dose and patient age
  • Monitor FBC
  • Adjust dose in renal impairment.

Mycophenolate mofetil is safer and as effective in lupus.

29
Q

When is methotrexate used?

A
RA - gold standard
Cancer
Psoriasis 
Crohn’s disease 
Other autoimmune rheumatic disease 

Can also be used for:
Inducing abortions. inflammatory myopathies, vasculitis, steroid-sparing agent in asthma

30
Q

What is the chemical structure of methotrexate similar to?

A

Folic acid

31
Q

How does methotrexate work in cancer?

A

Inhibiting folate synthesis.

Methotrexate competitively and reversibly inhibits dihydrofolate reductase.

The affinity is 1000x of folate.

Dihydrofolate reductase catalyses the conversion of dihydrofolate to tetrahydrofolate (active) the key carrier of C units in purine and thymidine synthesis.

Therefore, methotrexate inhibits the synthesis of DNA, RNA and proteins.

It has greater effects on cells that are rapidly dividing as it acts on S phase of the cell cycle.

32
Q

How does methotrexate work in RA?

A

MOA in non-malignant disease isn’t as clear because it is not via anti-folate action.

Possible mechanisms:
Inhibition of accumulation of adenosine
Inhibition of T cell activation
Suppression of intracellular adhesion molecule expression by T cells.

33
Q

What are the pharmacokinetics of methotrexate?

A
Mean oral bioavailability = 33%
Mean Im bioavailability = 76%
Administered PO, IM or SC
In patients taking PO with partial response or with nausea then swap to SC. 
50% protein bound - NSAIDs displace 
Renal excretion
34
Q

How often do you dose methotrexate?

A

Every week!

35
Q

Describe methotrexate in practise

A
Well tolerated.
50% of patients continue the drug for >5yrs, longer than any other DMARD
Improved QoL
Retardation of joint damage 
Anchor drug for DMARD combination.
36
Q

What are the ADRs of Methotrexate?

A

Mucositis (respond to folic acid)
Bone marrow suppression (respond to folic acid)

Hepatitis, cirrhosis
Pneumonia
Infection risk

Highly teratogenic. DON’T GET PREGNANT! Abortifacient

37
Q

What is sulfasalazine?

A

A conjugate of salicylate (anti-inflammatory) and sufapyridine (sulphonamide (antibiotic))
Developed in 1940s to relieve pain and stiffness. and also fight infection.

38
Q

What are the immunological effects of sulfasalazine?

A

T cell:
Inhibition of proliferation
Possible T-Cell apoptosis
Inhibition of IL-2 production.

Neutrophil:
Reduced chemotaxis
Reduced degranulation

39
Q

What ate the ADRs of sulfasalazine?

A
Myelosuppression
Hepatitis
Rash
Nausea
Abdo pain / vomiting
40
Q

How is Sulfasalazine used in practise?

A
Safe in pregnancy 
Effective
Favourable toxicity
Long term blood monitoring not always needed
Very few drug interactions 
No carcinogenic potential
41
Q

Describe characteristics of biological?

A

Extracted from living systems.g. whole blood + blood components or stem cell thrapy

Recombinant DNA technology producing substances that are (nearly) identical to the body’s own key signalling proteins.

Monoclonal antibodies “custom designed” to block specific substances int he body or target specific cells.

Receptor constructs (fusion proteins) usually based on naturally-occurring receptor, acting to block it.

42
Q

What are the effects of blocking TNF-a?

A

Decrease inflammation:
Cytokine cascade, recruitment of leukocyte to joint. - Elaboration of adhesion molecules, production of chemokine.

Decreased angiogenesis - VEGF levels

Decreased joint destruction -
MMPs and other destructive enzymes
Bone resorption and erosion
Cartilage breakdown

43
Q

What is Rituximab?

A

Binds specifically to a unique cell-surface marker CD20 which is found on a subset of B cells but not on stem cells, pro-B cells, plasm cells or another cell type.

Rituximab causes B cell apoptosis

Very effective in RA.

Good safety data.

44
Q

What is the BSRBP?

A

The PSR Biologics Register is the largest prospective observational register of rheumatology patients receiving anti-TNFa therapy in the world